Search PubMed⌕ Search

Biomedical subjects

Iu V Vasil'ev

Publications and source records attributed to Iu V Vasil'ev.

At least 19 recordsLinked to original sources
PubMed2002

[Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen].

The design of the medicamental treatment of the patients with duodenal ulcer disease associated with Helicobacter pylori is presented. It allows, as it was shown by our investigations, quickly to eliminate the pain in pyloroduodenal and (or) in epigastric areas and to achieve an adhesion of duodenal bulb ulcers according to the research protocol in 6 weeks. The eradication of Helicobacter pylori on the data of the fast urease test was determined in 9 of 10 patients. For getting more complete information about possibilities of using the given design of the medicamental preparations in the treatment of patients with duodenal ulcer disease associated with Helicobacter pylori, it is expedient to continue investigations in great numbers of the examined and treated patients.

Adult↗
PubMed2002

[Efficacy of the one week treatment with esomeprazole (nexium), clarythromycin, and amoxycillin of duodenal ulcer associated with Helicobacter pylori].

The results of one-week eradication therapy of uncomplicated duodenal ulcer disease associated with Helicobacter pylori by Ezomeprasol, Clarithromycin and Amoxicillin (accordingly 20 mg, 500 mg and 1000 mg twice per day) are presented. The results of the adhesion of uncomplicated ulcers of duodenal bulb in 4 weeks after termination of eradication treatment course--the adhesion of the ulcers was observed in 17 of 19 patients (89.5%). The eradication of Helicobacter pylori according the data of fast urease test and 13C-urease respiratory test was determined in all 19 patients (100%), on the data of histological method--in 18 of 19 patients (94.7%).

Amoxicillin↗
PubMed2002

[Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].

The results on estimation of efficiency and safety of monotherapy by Rabeprasol in dose 20 mg per day in treatment of the gastroesophageal reflux disease in an open clinical investigation are presented. It was found 100% of Rabeprasol efficiency in healing of erosion and diffuse pathological changes of esophagus mucous at gastroesofageal reflux disease: in 18 from 20 patients--for 4 weeks (90%) and in one patient--for 8 weeks; ulcers of esophagus--for 8 weeks of treatment in one patient. This medicine showed safety use practically without any serious complications; the side effects were insignificant and did not require the cancellation or resort any other medications.

2-Pyridinylmethylsulfinylbenzimidazoles↗
PubMed2002

[Apitherapy and problems in treating gastroenterology patients].

The disputable questions demanding the urgent decision on the development and specification of the recommendations and contraindications for using the honey and other beekeeping products in the therapy of various so-called gastroenterologic diseases are presented in this article. The aspects of efficiency and expediency of honey using as monotherapy and in complex combination with medicamentous preparations and (or) with other substances of national medicine are discussed.

Animals↗